Facebook
X
LinkedIn
Forward
February 2 - 6, 2015 - Grand Hyatt Kauai - Kauai, Hawaii
Course Directors: Friedman, Paul A., M.D. Packer, Douglas L., M.D.
Program Schedule
Program schedules are subject to change without notice.
Monday, February 2
| Time | Topic |
|---|---|
| 6:50 a.m. | Registration and Continental Breakfast |
| 7:10 a.m. | Welcome and Introductions (Pre-Test) Paul A. Friedman, M.D. |
| ATRIAL FIBRILLATION Moderator: Douglas L. Packer | |
| 7:30 a.m. | New Risk Factors for Atrial Fibrillation: Inflammation, Obesity, and Upstream Therapies Paul A. Friedman, M.D. |
| 7:55 a.m. | Achieving Rate Control for Atrial Fibrillation: Medications vs. AV Node Ablation Win-Kuang Shen, M.D. |
| 8:20 a.m. | Maintaining Sinus Rhythm: Following the AHA/ACC/HRS Guidelines and Practical Management Pearls David Haines, M.D |
| 8:45 a.m. | Preventing Stroke in Atrial Fibrillation: Which Medications, for Whom? Peter A. Noseworthy, M.D. |
| 9:10 a.m. | Panel Discussion Drs. Friedman, Haines, Shen, and Noseworthy |
| 9:30 a.m. | Refreshment Break |
| 10:00 a.m. | Managing Stroke in AF Without Drugs: Devices for Detection and Treatment Samuel J. Asirvatham, M.D. |
| 10:25 a.m. | Curative Ablation for Atrial Fibrillation: Whom to Treat, Expectations, and Post-Ablation Management Douglas L. Packer, M.D. |
| 10:50 a.m. | Surgical Therapies for Atrial Arrhythmias Rakesh M. Suri, M.D., D.Phil. |
| 11:15 a.m. | Bringing the Future Here: Novel Atrial Fibrillation Therapies Samuel J. Asirvatham, MD |
| 11:35 a.m. | Atrial Fibrillation & Flutter – Cases and Panel Moderator: Dr. Mulpuru Panelists: Drs. Asirvatham, Friedman, Haines, Packer, and Suri |
| 12:00 p.m. | Adjourn |
Tuesday, February 3
| Time | Topic |
|---|---|
| 6:30 a.m. | Continental Breakfast |
| VENTRICULAR ARRHYTHMIAS Moderator: Stephen C. Hammill, M.D. | |
| 7:00 a.m. | Special Session: Wide Complex Tachycardias Stephen C. Hammill, M.D. |
| 7:30 a.m. | The Cardiac Channelopathies: Who Needs Genetic Testing, Who Needs an ICD? Michael J. Ackerman, M.D., Ph.D. |
| 7:55 a.m. | Ablation Therapy in Patients in the Setting of Structural Heart Disease Siva K. Mulpuru, M.D. |
| 8:20 a.m. | Primary and Secondary Prevention of Sudden Death: Role of ICD Michael R. Gold, M.D., Ph.D. |
| 8:45 a.m. | ICD Management for the Non-EP Doc: Dealing with Everything from Cell Phones to Airports and from the Patient with Shocks To MRI Siva K. Mulpuru, M.D. |
| 9:10 a.m. | Panel Discussion Drs. Ackerman, Gold, and Mulpuru |
| 9:30 a.m. | Refreshment Break |
| 9:50 a.m. | The Great Debate: Arrhythmias in Athletes: Should They Play? Pro: Douglas L. Packer, M.D. Con: David E. Haines, M.D. |
| 10:20 a.m. | Identifying and Treating Idiopathic VT in the Normal Heart Peter A. Noseworthy, M.D. |
| 10:45 a.m. | Genetic Testing in Heart Disease: When Should We Do It, and How Does it Help? Michael J. Ackerman, M.D., Ph.D. |
| 11:10 a.m. | Role in Practice of New and Emerging Device Therapies to Treat Arrhythmias: |
| 11:30 a.m. | Case Based Workshop: Ventricular Arrhythmias Moderator: Samuel J. Asirvatham, M.D. Panelists: Drs. Ackerman, Friedman, Gold, Haines and Packer |
| 12:15 p.m. | Adjourn |
Wednesday, February 4
| Time | Topic |
|---|---|
| 6:30 a.m. | Continental Breakfast |
| ATRIAL FIBRILLATION Moderator: Douglas L. Packer, M.D. | |
| 7:00 a.m. | Special Session: Learning From the 12-lead ECG Stephen C. Hammill, M.D. |
| 7:30 a.m. | Diagnosis and Management of Congestive Heart Failure in Patients with Systolic Dysfunction Daniel D. Borgeson, M.D. |
| 7:55 a.m. | Heart Failure with Normal Systolic Function: What Is It and How Is It Treated? Jae K. Oh, M.D. |
| 8:20 a.m. | Keys to Selecting and Managing Patients Receiving CRT Systems Michael R. Gold, M.D., Ph.D. |
| 8:45 a.m. | Remote Monitoring: Current Role in Therapy for Heart Failure and Reducing Hospital Admissions Roy Small, M.D. |
| 9:10 a.m. | Panel Discussion Drs. Borgeson, Gold, Oh, and Small |
| 9:30 a.m. | Refreshment Break |
| 10:00 a.m. | Treatment Options for End Stage Heart Failure When Medications and CRT are not Helping: LVADs and Transplantation Brooks S. Edwards, M.D. |
| 10:25 a.m. | Sleep, Heart Failure, and Ventricular Arrhythmias Virend Somers, M.D., Ph.D. |
| 10:50 a.m. | Managing Atrial Fibrillation in Heart Failure Douglas L. Packer, M.D. |
| 11:10 a.m. | Case-Based Workshop: Heart Failure Management with Medications and Devices Moderator: Daniel D. Borgeson, M.D. Panelists: Drs. Gold, Edwards, Oh, Packer, and Small |
| 12:15 p.m. | Adjourn |
| 6:00 p.m. (Dinner) 7:00-8:00 p.m. (Lecture) | Special Wednesday Evening session Why Do We Get Fat and What Do We Do About It? Gary Taubes |
Thursday, February 5
| Time | Topic | |
|---|---|---|
| 6:30 a.m. | Continental Breakfast | |
| SPECIAL PATIENTS/SPECIAL CARE Moderator: Win-Kuang Shen, M.D. | ||
| 7:00 a.m. | Special Session: ECG Pearls for Diagnosing Heart Disease Stephen C. Hammill, M.D. | |
| 7:30 a.m. | The Healthy Heart and SVT: AV Node Reentry, WPW, and Atrial Tachycardia Kalpathi Venkatachalam, M.D. | |
| 7:55 a.m. | Challenges in the Young: POTS, Inappropriate Sinus Tachycardia, and Recurrent Vaso-Vagal Syncope Bryan C. Cannon, M.D. | |
| 8:20 a.m. | Syncope: Can I Drive or Not Kalpathi Venkatachalam, M.D. | |
| 8:45 a.m. | Panel Discussion Drs. Venkatachalam and Cannon | |
| 9:10 a.m. | Syncope, POTS, and IAST Cases Moderator: Win-Kuang Shen, M.D. Panelists: Drs. Venkatachalam, Cannon, and Srivathsan | |
| 9:25 a.m. | Refreshment Break | |
| 9:35 a.m. | Photo Contest | |
| RISK FACTOR MANAGEMENT | ||
| 9:45 a.m. | Roles of Foods, Lifestyle for Lipid Management Francisco Lopez Jimenez, M.D. | |
| 10:10 a.m. | Lifestyle and Drug Treatment for Hypertension Roger F. Shepherd, M.B., B.Ch. | |
| 10:35 a.m. | The New Lipid Guidelines: When are Statins Needed Francisco Lopez Jimenez, M.D. | |
| 11:00 a.m. | Interventional Treatments for Hypertension: State of the Art 2015 Rajiv Gulati, M.D., Ph.D. | |
| 11:25 a.m. | What Sort of Diet Promotes Wellness? What Does the Evidence Really Show? Gary Taubes | |
| 11:50 a.m. | Sleep, Hypertension, and Stroke: What You Need to Know for Practice Virend Somers, M.D., Ph.D. | |
| 12:15 p.m. | Panel Discussion Drs. Gulati, Lopez-Jimenez, and Shepherd | |
| 12:25 p.m. | Adjourn |
Friday, February 6
| Time | Topic |
|---|---|
| 6:30 a.m. | Continental Breakfast |
| MYOCARDIAL DISEASE Moderator: TBD | |
| 7:00 a.m. | Special Session: Using the ECG to Identify the Culprit Vessel Komandoor Srivathsan, M.D. |
| 7:30 a.m. | Special ECG for the Clinician Stephen C. Hammill, M.D. |
| 8:30 a.m. | Management of STEMI: Update 2015 Jae K. Oh, M.D. |
| 8:55 a.m. | Non-STEMI Rajiv Gulati, M.D., Ph.D. |
| 9:20 a.m. | Panel Discussion Drs. Hammill, Gulati and Oh, and Srivathsan |
| 9:35 a.m. | Refreshment Break |
| 9:50 a.m. | Post-Test |
| 10:05 a.m. | Amyloid Heart Disease: Now a Treatable Disease. Martha Grogan, M.D. |
| 10:30 a.m. | Dealing with Pericardial Disease: Diagnosis and Treatment Jae K. Oh, M.D. |
| 10:55 a.m. | PFO and Atrial Septal Defect: When Should you Close and How Martha Grogan, M.D. |
| 11:30 a.m. | Panel Discussion |
| 11:45 a.m. | Closing Comments and Course Overview |
| 12:00 p.m. | Adjourn |
Faculty
Mayo Clinic Faculty
- Michael J. Ackerman, M.D., Ph.D.
- Samuel J. Asirvatham, M.D.
- Daniel D. Borgeson, M.D.
- Bryan C. Cannon, M.D.
- Brooks S. Edwards, M.D.
- Martha Grogan, M.D.
- Rajiv Gulati, M.D., Ph.D
- Stephen C. Hammill, M.D.
- Francisco Lopez-Jimenez, M.D.
- Siva K. Mulpuru, M.D.
- Jae K. Oh, M.D.
- Peter A. Noseworthy, M.D.
- Win-Kuang Shen, M.D.
- Roger F. Shepherd, M.B., B.Ch.
- Virend Somers, M.D., Ph.D.
- Komandoor Srivathsan, M.D.
- Rakesh M. Suri, M.D., D.Phil.
- K. L. Venkatachalam, M.D.
Guest Faculty
- Michael R. Gold, M.D., Ph.D.
Michael E. Assey Professor of Medicine
Director of Cardiology
Medical University of South Carolina
Charleston, S.C. - David E. Haines, M.D.
Director, Heart Rhythm Center
Beaumont Heart & Vascular Center
Royal Oak, Mich. - Roy S. Small, M.D.
Director, Heart Failure Services
Medical director, Clinical Research
Lancaster General Health
Lancaster, Pa. - Gary Taubes
Author
Faculty Disclosure
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.